Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
166.8 SAR | +1.09% | +0.12% | -3.03% |
May. 15 | Dallah Healthcare Company Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 13 | Dallah Healthcare Posts Higher Q1 Net Profit, Revenue | MT |
Sales 2024 * | 3.3B 882M | Sales 2025 * | 3.56B 950M | Capitalization | 16.12B 4.3B |
---|---|---|---|---|---|
Net income 2024 * | 436M 116M | Net income 2025 * | 513M 137M | EV / Sales 2024 * | 5.39 x |
Net Debt 2024 * | 1.7B 455M | Net Debt 2025 * | 1.68B 447M | EV / Sales 2025 * | 5 x |
P/E ratio 2024 * |
37.3
x | P/E ratio 2025 * |
31.3
x | Employees | - |
Yield 2024 * |
1.49% | Yield 2025 * |
1.82% | Free-Float | 41.94% |
1 day | +0.48% | ||
1 week | -0.36% | ||
Current month | +0.48% | ||
1 month | -0.72% | ||
3 months | -9.99% | ||
6 months | -4.27% | ||
Current year | -3.49% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 67 | 08-03-28 | |
Salah Al-Faqih
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Talal Al-Maiman
BRD | Director/Board Member | - | - |
Chairman | 67 | 93-12-31 | |
Mohialdeen Kamel
BRD | Director/Board Member | 43 | 16-10-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 114 M€ | +4.36% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 166.8 | +1.09% | 54 435 |
24-06-09 | 165 | +0.36% | 58,808 |
24-06-06 | 164.4 | +0.74% | 65,967 |
24-06-05 | 163.2 | -1.57% | 81,429 |
24-06-04 | 165.8 | -0.36% | 78,582 |
Delayed Quote Saudi Arabian S.E., June 10, 2024 at 03:09 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.49% | 4.3B | |
-25.47% | 15.13B | |
-1.80% | 11.77B | |
+3.48% | 11.71B | |
+5.93% | 10.36B | |
+27.17% | 8.54B | |
-6.29% | 7.42B | |
+6.08% | 6.72B | |
+6.26% | 6.32B | |
+10.25% | 4.21B |
- Stock Market
- Equities
- 4004 Stock